VitalConnect VitalPatch

by VitalConnect  · Based in United States → — Real-time, continuous patient monitoring with wearable biosensor technology.
Cardiology Critical Care Emergency Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. It leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. The flagship product, VitalPatch, is a disposable, wireless biosensor worn on the torso that continuously records and transmits vital sign data to the VitalCloud server. This allows clinicians to monitor patient vitals in various settings, including in-hospital and remotely. The comprehensive solution includes the VitalPatch biosensor, VistaPhone or VistaTablet relay devices, the VistaPoint application for data collection, VitalCloud for secure storage, and the VistaCenter web-based application for clinicians to view and analyze patient data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Wearable biosensor (VitalPatch) for continuous monitoring
  • Real-time streaming of up to 11 vital signs, including live ECG
  • Detection of 21 cardiac arrhythmias using AI algorithms
  • Cloud-based platform (VitalCloud, VistaCenter) for data storage and analysis
  • Patient-carried relay devices (VistaPhone, VistaTablet) with VistaPoint application
  • Water-resistant (IPX7) for daily activities
  • 7-day (168-hour) continuous wear period per biosensor
  • Medical-grade, hypoallergenic adhesive with low skin irritation
  • Automated notifications for vital sign trends and patient-impacting events
  • Optional integration with third-party devices for SpO2, blood pressure, and weight

Use Cases

  • Cardiac monitoring (Mobile Cardiac Telemetry, Extended Holter, Event Recorder)
  • Remote Patient Monitoring (RPM) for various conditions
  • Hospital-at-Home programs
  • Inpatient monitoring in non-critical hospital wards
  • Chronic disease management
  • Clinical trials and pharmaceutical solutions

What Physicians Need to Know

ECG/EKG Analysis Capability
The VitalPatch provides continuous single-lead ECG monitoring. A sophisticated, cloud-based algorithm continuously analyzes the ECG stream.
Arrhythmia Detection Accuracy
The VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI-based ECG analysis solution, with another source indicating 22 unique arrhythmias can be identified. A pilot study demonstrated greater accuracy in detecting ventricular tachycardia patterns and other dysrhythmias/arrhythmias, while reducing false alarms. Arrhythmia detection sensitivity and positive predictivity are u2265 70%.
Cardiac Monitoring Integration
The VitalPatch continuously streams ECG and other vital signs to the secure VitalCloud and VistaCenteru00ae via a VistaPhone or VistaTablet relay device. It supports various cardiac monitoring modalities including Mobile Cardiac Telemetry (MCT), Extended Holter, Holter, and Event Recorder. Clinicians have 24/7 access to real-time and historic patient data through a secure URL.
Real-Time Alert Capability
The system offers near real-time arrhythmia detection and event notification. It provides real-time monitoring with customizable alerts within VistaCenter. Clinicians can receive notifications via text or email for vital sign trends or other patient-impacting events. The Smart Notifications Suite includes alerts for heart rate, respiration rate, vital sign max/min combinations, and fall detection.
Physician Tip

The VitalConnect VitalPatch offers a discreet, comfortable, and easy-to-use solution for continuous cardiac monitoring, enhancing patient compliance for extended periods. Its real-time, cloud-based ECG analysis and comprehensive arrhythmia detection capabilities can aid in timely diagnosis and intervention. Physicians can leverage the customizable alerts and 24/7 access to patient data for proactive management, both in-hospital and in remote patient monitoring settings. The ability to monitor additional vital signs like heart rate variability, respiratory rate, and activity provides a more holistic view of the patient's condition.

The VitalPatch integrates seamlessly with the VitalConnect ecosystem, utilizing a VistaPhone or VistaTablet as a relay device to transmit encrypted data to the secure VitalCloud and VistaCenter platform. This setup enables continuous data streaming and remote access for healthcare professionals. Optional integration with third-party devices can expand monitoring to include vital signs such as blood oxygen saturation, blood pressure, and weight.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
  • Subscription-based services; Partnerships with healthcare organizations; Monthly fees tied to clinical services; Widely covered by Medicare and private insurers
DeploymentCloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet).
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The VitalPatch is FDA-cleared (K192757) as a wireless remote monitoring system for continuous collection of physiological data in home and healthcare settings. It also received an Emergency Use Authorization (EUA) during COVID-19 for remote monitoring and detection of QT interval changes in hospitalized COVID-19 patients.

Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Emergency Medicine

What the Web Says

The VitalConnect VitalPatch is a wearable biosensor designed for continuous, real-time monitoring of vital signs in both hospital and remote settings. It's praised for its ease of use, comprehensive data collection, and ability to improve patient safety and clinical workflows. However, some concerns exist regarding cost, integration with existing EHR systems, and occasional sensor detachment.

Overall: Positive

Strengths

  • Continuous, real-time monitoring of multiple vital signs (ECG, HR, RR, temp, SpO2, fall detection, activity)
  • Lightweight, small, and comfortable for patients, promoting compliance
  • Wireless and mobile, allowing for patient ambulation and remote monitoring
  • Early detection of patient deterioration, potentially reducing readmissions and improving outcomes
  • Reduces nursing workload by automating vital sign collection
  • FDA-cleared and CE-marked, indicating regulatory approval and reliability

Limitations

  • Cost can be a barrier for some healthcare facilities, especially for large-scale deployment
  • Integration with existing Electronic Health Record (EHR) systems can be complex or require custom solutions
  • Occasional issues with sensor adhesion or detachment, particularly with active patients or certain skin types
  • Data overload for clinicians if not properly integrated into workflows and alert systems
  • Requires a gateway device for data transmission, which can add to infrastructure needs
  • Battery life, while generally good, needs to be managed for continuous long-term monitoring

Based on reviews from: VitalConnect Official Website, Healthcare IT News, MD+DI (Medical Device and Diagnostic Industry), Journal of Medical Internet Research, Clinical trials and studies (e.g., published on PubMed), Physician reviews and testimonials (various medical forums and publications)

Last updated: 2026-07-27

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate VitalConnect VitalPatch

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

VitalConnect
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
VitalConnect raised over $30 million in an oversubscribed Series F financing round to support the continued growth of its wireless patient monitoring systems used in hospital and home settings. The company reported tripling revenue from 2021 to 2022 and is on track to nearly double it again in 2023.
2023-07
VitalConnect
Feinstein Institutes AI researchers receive $3.1M NIH grant to develop hospital risk and prevention tools
Researchers at the Feinstein Institutes received a $3.1 million NIH grant to develop hospital risk and prevention tools using AI and machine learning, leveraging patient data collected by the VitalConnect VitalPatch. The study aims to create more accurate prediction models for in-hospital patient deterioration.
2023-09
PMC (Clinical and Translational Science)
Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge
This study evaluated the VitalPatch's performance against conventional vital sign methods and its feasibility in predicting blood-based acute inflammatory protein signatures. The VitalPatch continuously monitored heart rate, heart rate variability, respiratory rate, and skin temperature in healthy volunteers.
2024-02
MedTech Dive
VitalConnect raises $100M for heart monitor patch
VitalConnect secured $100 million in funding to accelerate the commercialization of its VitalPatch ambulatory cardiac monitoring device, which detects 21 different cardiac arrhythmias using AI and provides real-time monitoring of vital signs. The device competes with other patches like iRhythm's Zio.
2025-02
Taylor & Francis (Journal of Medical Systems)
Remote Monitoring of Patients with Heart Failure: Characteristics of Effective Programs and Implementation Strategies
This review highlights the VitalConnect VitalPatch as a commercially available device that continuously tracks ECG, skin temperature, and activity for heart failure patients. Studies suggest its efficacy in predicting heart failure hospitalizations, offering a tool for early intervention.
2025-06
MDPI (Sensors)
Wearable Devices in Healthcare Beyond the One-Size-Fits All Paradigm
The VitalConnect VitalPatch is identified as a medical-grade wearable monitor focusing on clinical biometric monitoring for specific medical applications. These devices offer robust physiological monitoring capabilities validated for clinical use.
2025-10
SEMI
SEMI Smart MedTech Initiative Identifies Obstacles and Opportunities to Scale Wearable Biosensors for Clinical Use
A paper by the SEMI Smart MedTech Initiative discusses the challenges in scaling wearable biosensors for clinical use, noting that FDA-cleared, Class II diagnostic wearables like the VitalConnect VitalPatch use multi-lead ECG electrodes. Regulatory complexities and data quality are key obstacles.
2026-06
MedTech Intelligence
Clinical Care Insights: AI Edge Computing & 2026 Market Moves
VitalConnect's VitalPatch received Saudi Arabia FDA approval, indicating continued vendor activity in remote cardiology. This highlights the global expansion and regulatory achievements of the VitalPatch.
2026-02

Videos

Product demos, reviews, and walkthroughs for VitalConnect VitalPatch.

View all on YouTube

Frequently Asked Questions

The VitalPatch RTM employs FDA-cleared artificial intelligence, developed by Cardiologs Technologies, to analyze ECG data and detect 21 different cardiac arrhythmias. This AI also supports predictive analytics, which has been shown to identify patient deterioration up to 17 hours in advance in non-ICU settings, potentially enabling earlier clinical intervention and improved patient outcomes.
The VitalPatch is an FDA-cleared Class 2 wearable biosensor for continuous physiological data collection in various healthcare settings. The VitalConnect platform, including its monitoring service and cloud infrastructure, is designed to be compatible with HIPAA and HITECH guidelines, ensuring that patient data, including AI-generated insights, is protected through encryption and secure access protocols.
The VitalPatch is not intended for critical care patients and should not be used as a standalone diagnostic monitor or to replace existing standard-of-care monitoring practices. Furthermore, heart rate, ECG, arrhythmia analysis, heart rate variability, R-R interval, and respiratory rate measurements are not intended for patients with pacemakers and may be inaccurate in such cases.
Unlike some traditional Holter monitors, VitalPatch RTM offers real-time, continuous monitoring of 21 cardiac arrhythmias and four key vital signs, with data instantly transmitted to a secure cloud for physician access. While competitors like iRhythm's Zio patch also exist, VitalPatch's real-time streaming and comprehensive vital sign monitoring, enhanced by AI, provide a more immediate and complete patient view.
VitalPatch services are widely covered by Medicare and private insurers, with monthly fees often tied to the associated clinical services. Patients are typically responsible for deductibles, co-pays, and any services not covered by their insurance, with VitalConnect providing invoices after receiving explanation of benefits.
The VitalConnect Solution is designed as an integrated platform, and while specific customization options for its proprietary AI algorithms are not detailed, it offers telehealth-enabled software and aims to streamline patient data in real-time. Integration with existing EHR systems is a common goal for RPM solutions to optimize care delivery and workflow efficiency.
The AI-based ECG analysis for arrhythmia detection is an adjunct to clinical assessment, meaning clinician review of the analysis is required before any therapeutic intervention. VitalConnect's cardiac monitoring center, staffed by nationally certified technicians, oversees continuous ECG and physiological data, confirming AI results and providing timely notifications to prescribing physicians.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from VitalConnect

VitalRhythm
VitalConnect
Cardiology AI
VitalRhythm by VitalConnect is an AI-powered cloud-based software for continuous cardiac arrhythmia detection and analysis, integrating with the VitalPatch biosensor for remote patient monitoring.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-27 | First Added: 2026-04-27

Investors who backed VitalConnect VitalPatch

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.